Key points are not available for this paper at this time.
Rheumatoid arthritis (RA) is usually associated with excessive proliferation of M1-type proinflammatory macrophages, resulting in severe hypoxia and excess reactive oxygen species (ROS) in the joint cavity. Inhibiting M1-type proinflammatory macrophages and/or repolarizing them into M2 phenotype anti-inflammatory cells by alleviating hypoxia and scavenging ROS could be a promising strategy for RA treatment. In this work, a microwave-sensitive metal–organic framework of UiO-66-NH 2 is constructed for coating a nanoenzyme of cerium oxide (CeO 2 ) and loading with the drug celastrol (Cel) to give UiO-66-NH 2 /CeO 2 /Cel, which is ultimately wrapped with hyaluronic acid (HA) to form a nanocomposite UiO-66-NH 2 /CeO 2 /Cel@HA (UCCH). With the microwave-susceptible properties of UiO-66-NH 2, the thermal effect of microwaves can eliminate the excessive proliferation of inflammatory cells. In addition, superoxide-like and catalase-like activities originating from CeO 2 in UCCH are boosted to scavenge ROS and accelerate the decomposition of H 2 O 2 to produce O 2 under microwave irradiation. The nonthermal effect of microwaves could synergistically promote the repolarization of M1-type macrophages into the M2 phenotype. Accompanied by the release of the anti-RA chemotherapeutic drug Cel, UCCH can efficiently ameliorate RA in vitro and in vivo through microwave-enhanced multisynergistic effects. This strategy could inspire the design of other multisynergistic platforms enhanced by microwaves to exploit new treatment modalities in RA therapies.
Zhang et al. (Wed,) studied this question.